Challenger Rejects Daiichi Life Unit's A$11.80 Per Share Takeover Bid

Challenger Limited said an indicative proposal from TAL Daiichi Life Australia Pty to buy more than 79% of its shares is not at a level it could recommend to shareholders. The future of trading reported that the A$11.80 per share bid values the Australian investment manager at A$7.94 billion, or $5.58 billion.

Challenger is Australia's largest annuities provider and one of its largest active fund managers, offering lifetime and fixed term annuities, aged-care income solutions, and institutional retirement and reinsurance products. TAL Daiichi Life Australia is a unit of Japan's Daiichi Life, which is the parent firm of the Australian insurer.

Challenger's Board Response to the Daiichi Life Proposal

Challenger said on Monday its board intends to engage with TAL Daiichi Life Australia Pty to see whether a proposal can be reached that the board could recommend. The company said in its statement: "There is no certainty that the proposal will result in a binding offer or that any transaction will eventuate."

Earlier this month, TAL Daiichi Life Australia made the indicative proposal of A$11.80 per share. Daiichi Life, the parent firm of TAL Daiichi Life Australia, did not immediately respond to a Reuters request for comment, according to the report.

Challenger's Annuity and Reinsurance Operations

Challenger Limited manages more than $124 billion in assets and is Australia's largest annuities provider, according to akta.pro company records. The group paid about A$5 billion in annuity interest and capital payments to customers in FY25, and about A$6 billion in FY24.

In May 2026, Challenger completed the acquisition of a $3.62 billion whole-of-loan equipment finance portfolio from Bank of Queensland, expanding the annuity Statutory Fund's interest-earning asset base. The same records show Challenger established Calix Re Limited, a Class E licensed Bermuda reinsurance subsidiary focused on Japan-based fixed term annuities through a long-standing reinsurance partnership, with initial capital provided by Challenger.

Daiichi Life's Earlier Offer for Challenger

On October 18, 2026, Bloomberg reported that Daiichi Life Group offered to buy the remaining 79.5% of Challenger Ltd. at A$11.80 per share, valuing the firm at about A$7.9 billion. The offer was roughly 20% above Friday's closing price and valued the stake Daiichi Life does not own at A$6.3 billion.

In September 2026, AInvest reported that Challenger Limited is buying back up to A$450 million in shares, funded by capital freed from APRA's new solvency framework. The buy-back, plus a dividend raise, reflected the regulator's new rules reducing required capital.

Next Steps for the Proposal

Challenger said its board intends to engage with TAL Daiichi Life Australia Pty to see whether a proposal can be reached that the board could recommend. The company said there is no certainty that the proposal will result in a binding offer or that any transaction will eventuate.